Lv11
88 积分 2025-06-06 加入
Overcoming limitations and advancing the therapeutic potential of antibody-oligonucleotide conjugates (AOCs): Current status and future perspectives
4小时前
待确认
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
7天前
已完结
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
2个月前
已完结
Intra-channel bi-epitopic crosslinking unleashes ultrapotent antibodies targeting NaV1.7 for pain alleviation
3个月前
已完结
Intra-channel bi-epitopic crosslinking unleashes ultrapotent antibodies targeting NaV1.7 for pain alleviation
3个月前
已完结
A robust heterodimeric Fc platform engineered for efficient development of bispecific antibodies of multiple formats
3个月前
已完结
Development of an allosteric adhesion GPCR nanobody with therapeutic potential
3个月前
已完结
Rapidly accelerated development of neutralizing COVID‐19 antibodies by reducing cell line and CMC development timelines
6个月前
已完结
A high‐fidelity, dual site‐specific integration system in CHO cells by a Bxb1 recombinase
6个月前
已完结
皖公网安备34019202002308
